ArticleInternational journal of molecular sciences2025
Sex-Specific Improvements in Myocardial Function and Angiogenesis with SGLT-2 Inhibitor Canagliflozin in a Swine Model of Metabolic Syndrome.
Dwight D Harris, Mark Broadwin, Christopher Stone, Sharif A Sabe, Meghamsh Kanuparthy, Ju-Woo Nho, Kelsey C Muir, M Ruhul Abid, Frank W Sellke
Abstract read
In one paragraphArticle in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
9 authors.
Dwight D HarrisDivision of Cardiothoracic Surgery, Department of Surgery, Cardiovascular Research Center, Alpert Medical School of Brown University, Brown University Health, 2 Dudley Street, MOC 360, Providence, RI 02905, USA.
Mark BroadwinDivision of Cardiothoracic Surgery, Department of Surgery, Cardiovascular Research Center, Alpert Medical School of Brown University, Brown University Health, 2 Dudley Street, MOC 360, Providence, RI 02905, USA.ORCID 0000-0002-0393-9983 Christopher StoneDivision of Cardiothoracic Surgery, Department of Surgery, Cardiovascular Research Center, Alpert Medical School of Brown University, Brown University Health, 2 Dudley Street, MOC 360, Providence, RI 02905, USA.
Sharif A SabeDivision of Cardiothoracic Surgery, Department of Surgery, Cardiovascular Research Center, Alpert Medical School of Brown University, Brown University Health, 2 Dudley Street, MOC 360, Providence, RI 02905, USA.ORCID 0000-0002-8169-6753 Meghamsh KanuparthyDivision of Cardiothoracic Surgery, Department of Surgery, Cardiovascular Research Center, Alpert Medical School of Brown University, Brown University Health, 2 Dudley Street, MOC 360, Providence, RI 02905, USA.ORCID 0009-0005-7581-0555 Ju-Woo NhoDivision of Cardiothoracic Surgery, Department of Surgery, Cardiovascular Research Center, Alpert Medical School of Brown University, Brown University Health, 2 Dudley Street, MOC 360, Providence, RI 02905, USA.ORCID 0009-0006-1260-070X Kelsey C MuirDivision of Cardiothoracic Surgery, Department of Surgery, Cardiovascular Research Center, Alpert Medical School of Brown University, Brown University Health, 2 Dudley Street, MOC 360, Providence, RI 02905, USA.
M Ruhul AbidDivision of Cardiothoracic Surgery, Department of Surgery, Cardiovascular Research Center, Alpert Medical School of Brown University, Brown University Health, 2 Dudley Street, MOC 360, Providence, RI 02905, USA.
Frank W SellkeDivision of Cardiothoracic Surgery, Department of Surgery, Cardiovascular Research Center, Alpert Medical School of Brown University, Brown University Health, 2 Dudley Street, MOC 360, Providence, RI 02905, USA.ORCID 0000-0002-8886-801X Funding
CARDIOPLEGIA AND CORONARY MICROVASCULAR REACTIVITYR01HL046716 · BETH ISRAEL DEACONESS MEDICAL CENTER · 1997 to 2004
$1.5MStem Cells and AgingP30GM145500 · RHODE ISLAND HOSPITAL · 2025 to 2025
$1.2MVascular Dysfunction in Myocardial Ischemia and Metabolic SyndromeR01HL128831 · RHODE ISLAND HOSPITAL · 2025 to 2025
$818kCardiovascular Surgery Research TrainingT32HL160517 · RHODE ISLAND HOSPITAL · 2025 to 2025
$338kNHLBI NIH HHS F32 HL160063NHLBI NIH HHS R01 HL046716NHLBI NIH HHS R01 HL128831NHLBI NIH HHS R01 HL133624NHLBI NIH HHS R56 HL133624NHLBI NIH HHS T32 HL160517NIGMS NIH HHS P20 GM103652NIGMS NIH HHS P30 GM145500NIH HHS R01HL128831
6 · The paper itselfAbstract
There is a significant body of literature to suggest that coronary artery disease (CAD) is a highly sex-specific disease. The study of sex-specific therapeutics and sex-specific responses to treatment for CAD remains underreported in the literature. Sodium-glucose transporter 2 (SGLT2) inhibitors are of growing interest in the treatment of ischemic heart disease and heart failure; however, the sex-specific response to SGLT2 inhibitors is unknown. We studied an SGLT2 inhibitor, canagliflozin, in a swine model of metabolic syndrome (MS) and chronic myocardial ischemia with emphasis on the sex-specific outcomes. Yorkshire swine (
Indexed as
CanagliflozinHeartMetabolic SyndromeNeovascularization, PhysiologicSodium-Glucose Transporter 2 InhibitorsAngiogenesisAnimalsDisease Models, AnimalFemaleMaleMyocardial IschemiaMyocardiumSex FactorsSwineCanagliflozinSodium-Glucose Transporter 2 Inhibitorsameroid constrictorcanagliflozinchronic myocardial ischemiafemalemalemetabolic syndromesexsodium-glucose cotransporter-2 inhibitor
Identifiers
PMID40076513
PMCPMC11900068
What Socratic holds
Texttitle and abstract
LicenceCC BY
Read underepoch 390